TABLE 2.

Inhibition percentages of dual-species C. albicans–S. aureus and C. albicans–S. epidermidis biofilm formation on BSs treated silicone discs by CV (biofilm biomass) and MTT assays (biofilm metabolic activity).

Strains	Assessment	Time (h)	Treatment
			AC7BS (%)	R89BS (%)	SL18 (%)
C–Sa	Biofilm biomass	24	95.1	96.9	95.6
		48	90.2	96.7	91.8
		72	87.3	94.6	93.1
	Biofilm metabolic activity	24	95.6	97.2	95.8
		48	90.0	96.3	92.6
		72	82.8	92.0	90.3
C–Se	Biofilm biomass	24	−	96.1	94.4
		48	−	97.7	86.1
		72	−	91.0	78.8
	Biofilm metabolic activity	24	−	96.5	94.5
		48	−	94.1	86.7
		72	−	89.8	74.4

C–Sa, C. albicans–S. aureus; C–Se, C. albicans–S. epidermidis; −, not evaluated.